Keywords: زمان حداکثر غلظت; ANOVA; analysis of variance; AUC0â¿¿24; area under the curve of blood concentration vs. time from tâ¿¿=â¿¿0 to tâ¿¿=â¿¿24 after oral administration; BA; oral bioavailability; Cmax; maximum concentration; CWM; cold wet-milling; CoQ10; coenzyme Q10; DSC; di
مقالات ISI زمان حداکثر غلظت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: زمان حداکثر غلظت; AUC; area under the curve; BMI; body mass index; BODIPY; 4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-/s/-indacene-3-undecanoic acid; BP; blood pressure; CHD; coronary heart disease; CJC; cranberry juice cocktail; Cmax; maximum concentratio
Amorphous Solid Dispersion of Meloxicam Enhanced Oral Absorption in Rats With Impaired Gastric Motility
Keywords: زمان حداکثر غلظت; amorphous; drug-excipient interaction; gastrointestinal transit; oral absorption; poorly water-soluble drugs; solid dispersion; AUC; area under the curve of blood concentration versus time curve; ASD-MEL/EUD; amorphous solid dispersion of meloxicam with p
Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology
Keywords: زمان حداکثر غلظت; ANOVA; analysis of variance; AUC; area under the curve of plasma concentration vs. time; BA; oral bioavailability; BCS; biopharmaceutics classification system; BMA; butyl methacrylate; Cmax; maximum concentration; DLS; dynamic light scattering; GI; gastro
Idarubicin-Loaded ONCOZENE Drug-Eluting Embolic Agents for Chemoembolization of Hepatocellular Carcinoma: In Vitro Loading and Release and In Vivo Pharmacokinetics
Keywords: زمان حداکثر غلظت; AE; adverse event; AUC0-24 h; area under the concentration-time curve from 0-24 hours; Cmax; maximum concentration; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma; LLOQ; lower limit of quantification; MDR; multidrug resistance; PK; pharmacok
Cardiovascular pharmacologyCardiovascular safety pharmacology profile of etamicastat, a novel peripheral selective dopamine-Ã-hydroxylase inhibitor
Keywords: زمان حداکثر غلظت; DBH; dopamine-Ã-hydroxylase; LC-MS/MS; liquid chromatography - mass spectrometry; AUC; area under plasma concentration-time curve; tmax; time to maximum concentration; t1/2; terminal half-life; Cmax; maximum concentration; LLOQ; lower limit of quanti
Preclinical pharmacokinetic evaluation and metabolites identification of methyl salicylate-2-O-β-d-lactoside in rats using LC-MS/MS and Q-TOF-MS methods
Keywords: زمان حداکثر غلظت; AS; salicylic acid; AUC; area under the blood concentration-time curve; Cmax; maximum concentration; ESI; electrospray ionization; IS; internal standard; LC-MS/MS; liquid chromatography-mass spectrometry/mass spectrometry; MSL; methyl salicylate-2-O-β-
Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria
Keywords: زمان حداکثر غلظت; ANOVA; analysis of variance; AUC; area under the curve of blood concentration vs. time; BA; bioavailability; Cmax; maximum concentration; CV; coefficient of variation; DP; dipyridamole; DPG; granule formulation of dipyridamole; FA; fumaric acid; HCl; hydr
Novel formulations of dipyridamole with microenvironmental pH-modifiers for improved dissolution and bioavailability under hypochlorhydria
Keywords: زمان حداکثر غلظت; ANOVA; analysis of variance; API; active pharmaceutical ingredient; AA; adipic acid; D; l-aspartic acid; AUC; area under the curve of plasma concentration vs. time; BCS; biopharmaceutics classification system; CA; citric acid monohydrate; Cmax; maximum co